Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Ellis Andrea
Over the trailing 90 days, Ellis Andrea (Director at BridgeBio Pharma, Inc.) traded $1.7M of stock (net selling $1.2M) in BBIO, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- BBIO
- Window
- Trailing 90 days · 5 transactions · CIK 1877680
- Net activity
- −$1.2M ($288K bought · $1.4M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 5 | $288K | $1.4M | −$1.2M |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-09 | BBIO | Sell | 17.2K | $0 | Exercise or conversion of derivative security |
| 2026-07-09 | BBIO | Sell | 17.2K | $1.4M | Open market or private sale |
| 2026-07-09 | BBIO | Buy | 17.2K | $288K | Exercise or conversion of derivative security |
| 2026-06-22 | BBIO | Buy | 5.3K | $0 | Grant, award or other acquisition |
| 2026-06-22 | BBIO | Buy | 4.0K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Ellis's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.